Our findings underscore the pivotal role of P300/CBP in ES malignancy, as evidenced by a robust correlation between patient stratification based on specific EWS::FLI1/P300/CBP-related gene expression patterns and overall survival rates. This evidence concerns the gene FLI1 and Ewing sarcoma.